Home
Diseases
Adrenal Insufficiency

Adrenal Insufficiency

Disease

Disease Profile

Adrenal insufficiency is a condition in which the adrenal glands do not produce adequate steroid hormones, including cortisol and sometimes aldosterone. Deficiency can lead to fatigue, hypotension, gastrointestinal symptoms, and in severe stress states adrenal crisis.

Category: endocrine_disorder

ICD Codes

E27.40

Related News

Relacorilant-nab-paclitaxel Improves Survival in Ovarian Cancer Despite Prior Taxane Use

May 30, 2026

The phase 3 ROSELLA trial showed relacorilant plus nab-paclitaxel significantly improved overall survival in platinum-resistant ovarian cancer by 4.1 months versus nab-paclitaxel alone. The benefit was consistent across all subgroups regardless of prior taxane exposure, leading to FDA approval in March 2026. The combination also met its progression-free survival endpoint and demonstrated a favorable safety profile.

Biomarkers and outcomes in checkpoint inhibitor-associated diabetes and hyperglycemia

Apr 19, 2026

Studies on immune checkpoint inhibitor therapy found pretreatment biomarkers strongly predicted checkpoint inhibitor-associated autoimmune diabetes, while hyperglycemia during treatment was common and did not worsen disease progression.

FDA Approves Lifyorli Plus Nab-Paclitaxel for Platinum-Resistant Ovarian Cancer

Mar 26, 2026

The FDA has approved Lifyorli (relacorilant) plus nab-paclitaxel for platinum-resistant ovarian cancer based on trial data showing improved survival. Separately, the agency granted Breakthrough Therapy designation to Lilly's sofetabart mipitecan for the same condition, expediting development of the antibody-drug conjugate.

FDA Approves Pembrolizumab Combinations for Platinum-Resistant Ovarian Cancer

Feb 12, 2026

The FDA approved pembrolizumab (Keytruda) and Keytruda Qlex plus paclitaxel, with or without bevacizumab, for adults with PD-L1+ platinum-resistant ovarian carcinoma based on Phase 3 trial data showing improved survival outcomes.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT07168122	Establishment and Clinical Application of Reference Intervals of Salivary Cortisol	RECRUITING
NCT06980753	Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders	NOT_YET_RECRUITING	NA
NCT06955286	Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion	RECRUITING
NCT06861530	A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children	RECRUITING
NCT06637722	Self-management in Patients With Adrenal Insufficiency.	ACTIVE_NOT_RECRUITING
NCT06608433	Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function	COMPLETED	NA
NCT06435481	Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics	NOT_YET_RECRUITING	PHASE4
NCT06430528	A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement	RECRUITING
NCT06309498	Residual Adrenal Function in Addison's Disease	RECRUITING
NCT06260462	Effects of Steroid Replacement Therapy on Metabolic, Cardiovascular and Bone Outcomes in Adrenal Insufficiency	COMPLETED	PHASE3